Mirvetuximab Biosimilar - Research Grade
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Mirvetuximab
Specifications
Detects human FOLR1
Species Reactivity
Human
Target
FOLR1
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Explore Other Products
Browse additional items from our catalog
CDC2L5 (Cell Division Cycle 2-like 5 (Cholinesterase-Related Cell Division controller), CDC2L, CHED, FLJ35215, KIAA1791) (MaxLight 750)
CDC2L5 (Cell Division Cycle 2-like 5 (Cholinesterase-Related Cell Division controller), CDC2L, CHED, FLJ35215, KIAA1791) (MaxLight 750)
GDPD2, ID (GDPD2, GDE3, OBDPF, Glycerophosphoinositol inositolphosphodiesterase GDPD2, Glycerophosphodiester phosphodiesterase 3, Glycerophosphodiester phosphodiesterase domain-containing protein 2, Osteoblast differentiation promoting factor)
GDPD2, ID (GDPD2, GDE3, OBDPF, Glycerophosphoinositol inositolphosphodiesterase GDPD2, Glycerophosphodiester phosphodiesterase 3, Glycerophosphodiester phosphodiesterase domain-containing protein 2, Osteoblast differentiation promoting factor)